Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome

NCT: NCT07490444 · RECRUITING

NCT IDNCT07490444
StatusRECRUITING
Start Date2026-07-13
Completion2028-05-01
SponsorOhio State University (OTHER)
First posted
Last updated

Brief Summary

This study seeks to determine whether glasses prescriptions determined from computer analysis of detailed images of the eyes provide better vision outcomes for children with Down syndrome than prescriptions determined using routine clinical methods.

Frequently Asked Questions

What is Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome?

Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome is a clinical trial registered under NCT07490444. Current status: RECRUITING.

What is the status of NCT07490444?

The current status of NCT07490444 (Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome) is: RECRUITING.

When did Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome start?

Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome started on 2026-07-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.